Italy· 036643017
GLICLAZIDE PENSA
A gliclazide product containing gliclazide, registered in Italy by TOWA PHARMACEUTICAL S.P.A., on the national reimbursement list. The same ATC class is registered in 14 of our 19 countries.
Checked against AIFA (Italy) on
Informational only — not a medical device.
Where it is registered
Gliclazide is registered in 14 of 19 countries.
Countries holding a registration under ATC A10BB09 (gliclazide), each read from that country’s own register.
- This record: Italy, from AIFA (Italy)
- 7 of them publish a price we can compare per daily dose
Gliclazide · ATC A10BB09
14 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Polandprice
- Switzerlandprice
- United Kingdom
Price per daily dose
What a daily dose of gliclazide costs, country by country.
Normalised to the WHO defined daily dose (60 mg), the median price runs from $0.11 in France to $0.61 in Switzerland — a ×5.5 gap.
- Italy: $0.26 per daily dose (median across products in the class)
- Public list prices, converted to USD at the rate date shown
Gliclazide · price per daily dose (60 mg)
USD · FX 28 Sept 2026
- CH Switzerland$0.61
- IT Italy$0.26
- FR France$0.11
The record
At a glance
AIFA (Italy)- Active substance
- Gliclazide
- Manufacturer
- TOWA PHARMACEUTICAL S.P.A.
- Country
- Italy (IT)
- ATC code
- A10BB09
- ATC class
- Gliclazide
- Defined daily dose
- 60 mg, O
- Reimbursed
- Yes
- Source register
- AIFA (Italy)
- Last checked
- September 28, 2026
Packs & prices · 1
1 priced- aic036643017"80 MG COMPRESSE" 40 COMPRESSE DIVISIBILIEUR 3.34
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
5 interactions on record for gliclazide.
Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Gliclazide · interactions on record
5 records
5 more interactions with mechanism and management, from a commercially licensed source.
Sign in to checkSame medicine, other countries
Gliclazide in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomDiaglyk 80mg tabletsAshbourne Pharmaceuticals Ltd
- FranceGLICLAZIDE BIOGARAN 80 mg, comprimé sécableBIOGARAN
- CanadaAPO-GLICLAZIDEAPOTEX INC
- PolandDiabrezideL.Molteni & C. dei F.lli Alitti Societa di Esercizio S.p.A.
- CzechiaDIAPREL MRLes Laboratoires Servier, Suresnes cedex
- SpainDIAMICRON 30 mg COMPRIMIDOS DE LIBERACION MODIFICADALes Laboratoires Servier
- SwitzerlandDiamicron MR
- NetherlandsDIAMICRON MR 30 mg, tabletten met gereguleerde afgifteLes Laboratoires Servier
Authorised across Europe · EMA
The same active substance is authorised in 26 EEA countries. Names it is sold under:
- Austria · Diamicron Mr, Gliclada
- Belgium · Gliclazide Sandoz, Uni Diamicron
- Bulgaria · Гликлада, Диаб
- Cyprus · Diamicron, Glicron
- Czechia · Diaprel Mr, Gliclazid Viatris
- Germany · Diamicron Uno, Glibemat
- Denmark · Diamicron Uno, Gliclazid Krka
- Estonia · Diaprel, Diaprel Mr
- Spain · Diamicron, Gliclazida Aurovitas
- France · Diamicron, Diamicron 60 Mg
- United Kingdom (Northern Ireland) · Dacadis Mr, Diamicron
- Greece · Diamicron, Diamicron Mr
- Croatia · Diaprel Mr, Gliclada
- Hungary · Diaprel Mr, Gliclada
- Ireland · Diaclide Mr, Diacronal Mr
- Iceland · Diamicron Uno, Gliclatim
- Lithuania · Diaprel Mr, Gliclada
- Luxembourg · Diamicron, Uni Gliclazide Eg
- Latvia · Diaprel Mr, Gliclada
- Malta · Diamicron, Gliclazide Bp Accord Healthcare
- Netherlands · Diamicron Mr, Gliclazide Aurobindo
- Poland · Clazicon, Diabrezide
- Portugal · Diamicron Lm, Gliclazida Alter
- Romania · Diaprel Mr, Gliclazide Gemax Pharma
- Slovenia · Diaprel, Diaprel Mr
- Slovakia · Diaprel Mr, Gliclada
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of AIFA (Italy). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e6143cd5-61be-4a19-b204-2c8d59d2d441 GET /v1/drugs/e6143cd5-61be-4a19-b204-2c8d59d2d441?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"pack": "\"80 MG COMPRESSE\" 40 COMPRESSE DIVISIBILI",
"source": "aifa",
"currency": "EUR",
"substance": "Gliclazide",
"reference_pack": "40 UNITA' 80 MG - USO ORALE",
"public_price_eur": 3.34,
"ssn_reference_price_eur": 3.34
}See everything about gliclazide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.